Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
6.12
+0.06 (0.99%)
Jul 3, 2026, 3:00 PM CST
10.67% (1Y)
| Market Cap | 4.31B +17.0% |
| Revenue (ttm) | 358.90M +1.7% |
| Net Income | -171.66M |
| EPS | -0.24 |
| Shares Out | 703.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 44,417,144 |
| Open | 6.06 |
| Previous Close | 6.06 |
| Day's Range | 5.85 - 6.14 |
| 52-Week Range | 4.01 - 7.05 |
| Beta | 0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 31, 2026 |